Donna L. Lancaster - Concepedia

Author

Donna L. Lancaster

Also Known As

D L Lancaster, D. L. Lancaster, D.L. Lancaster, Donna L Lancaster, Donna L. Lancaster

Publications

296

Citations

H-Index

Concepts

All Affiliations

Donna L. Lancaster is an author at Royal Marsden NHS Foundation Trust specializing in cancer research, pediatrics, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	83
2	Health Sciences	1	1	51
3	Immunology	1	1	51
4	Pathology	1	1	51
5	Pharmacology	1	1	32

Donna L. Lancaster

Publications

285

Citations

H-Index

Page 1

	Year	Citations
Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium C. Michel Zwaan, Carmelo Rizzari, Françoise Méchinaud, Journal of Clinical Oncology	2013	93
Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia Parameswaran Anoop, S Sankpal, Charles Stiller, Leukemia & lymphoma/Leukemia and lymphoma Mixed-phenotype Acute LeukemiaImmunologyPathologyImmunotherapyHematological Malignancy	2012	51
6‐Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6‐thioguanine nucleotide concentrations Donna L. Lancaster, Nishith Patel, Lynne Lennard, British Journal of Clinical Pharmacology	2001	41
Inhibition of Metoprolol Metabolism by Chloroquine and other Antimalarial Drugs Donna L. Lancaster, Risquat A. Adio, Kwok‐Keung Tai, Journal of Pharmacy and Pharmacology	1990	38
Toxicity and Outcome of Children and Adolescents Participating in Phase I/II Trials of Novel Anticancer Drugs Daniel A. Morgenstern, Darren Hargrave, Lynley V. Marshall, Journal of Pediatric Hematology/Oncology Chemoprevention StrategyCancer ManagementEarly Phase TrialsPharmacotherapyOncology	2013	32
Tolerance of Nitrosurea-Based Multiagent Chemotherapy Regime for Low-Grade Pediatric Gliomas Donna L. Lancaster, Jane Hoddes, Antony Michalski Journal of Neuro-Oncology	2003	30

Page 1